Quantum polarized ligand docking investigation to understand the significance of protonation states in histone deacetylase inhibitors

Martínez-Iglesias, 2008, Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer, Clinical and Translational Oncology, 10, 395, 10.1007/s12094-008-0221-x Kuo, 1998, Roles of histone acetyltransferases and deacetylases in gene regulation, BioEssays, 20, 615, 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H Grunstein, 1997, Histone acetylation in chromatin structure and transcription, Nature, 389, 349, 10.1038/38664 Grozinger, 2002, Deacetylase enzymes: biological functions and the use of small-molecule inhibitors, Chemistry and Biology, 9, 3, 10.1016/S1074-5521(02)00092-3 Mottet, 2008, Histone deacetylases: target enzymes for cancer therapy, Clinical and Experimental Metastasis, 25, 183, 10.1007/s10585-007-9131-5 Matsushita, 2006, In vivo analysis of the role of aberrant histone deacetylase recruitment and RARα blockade in the pathogenesis of acute promyelocytic leukemia, Journal of Experimental Medicine, 203, 821, 10.1084/jem.20050616 Gallinari, 2007, HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics, Cell Research, 17, 195, 10.1038/sj.cr.7310149 Hagelkruys, 2011, The biology of HDAC in cancer: the nuclear and epigenetic components, 206, 13 Hodawadekar, 2007, Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design, Oncogene, 26, 5528, 10.1038/sj.onc.1210619 Dokmanovic, 2005, Prospects: histone deacetylase inhibitors, Journal of Cellular Biochemistry, 96, 293, 10.1002/jcb.20532 Bradner, 2010, Chemical phylogenetics of histone deacetylases, Nature Chemical Biology, 6, 238, 10.1038/nchembio.313 Weerasinghe, 2008, Residues in the 11 Ã channel of histone deacetylase 1 promote catalytic activity: implications for designing isoform-selective histone deacetylase inhibitors, Journal of Medicinal Chemistry, 51, 5542, 10.1021/jm800081j Tang, 2009, Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation, Journal of Chemical Information and Modeling, 49, 461, 10.1021/ci800366f Huang, 2005, Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1//WAF1 expression, independent of histone deacetylase 1, Cell Death and Differentiation, 12, 395, 10.1038/sj.cdd.4401567 Zhu, 2004, Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis, Cancer Cell, 5, 455, 10.1016/S1535-6108(04)00114-X Lin, 1998, Role of the histone deacetylase complex in acute promyelocytic leukaemia, Nature, 391, 811, 10.1038/35895 Neal, 2012, Complex role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer, Journal of Clinical Oncology, 30, 2280, 10.1200/JCO.2011.41.0860 Marks, 2004, 91, 137 Lyssiotis, 2011, Chemical control of stem cell fate and developmental potential, Angewandte Chemie International Edition, 50, 200, 10.1002/anie.201004284 Garber, 2007, HDAC inhibitors overcome first hurdle, Nature Biotechnology, 25, 17, 10.1038/nbt0107-17 Mai, 2005, Histone deacetylation in epigenetics: an attractive target for anticancer therapy, Medicinal Research Reviews, 25, 261, 10.1002/med.20024 Balakin, 2007, Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective, Anti-Cancer Agents in Medicinal Chemistry, 7, 576, 10.2174/187152007781668698 Kalyaanamoorthy, 2012, Exploring inhibitor release pathways in histone deacetylases using random acceleration molecular dynamics simulations, Journal of Chemical Information and Modeling, 52, 589, 10.1021/ci200584f Finnin, 1999, Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors, Nature, 401, 188, 10.1038/43710 Schapira, 2011, Structural biology of human metal-dependent histone deacetylases, 206, 225 de Ruijter, 2003, Histone deacetylases (HDACs): characterization of the classical HDAC family, Biochemical Journal, 370, 737, 10.1042/bj20021321 Somoza, 2004, Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases, Structure (London, England: 1993), 12, 1325, 10.1016/j.str.2004.04.012 Gantt, 2010, Activation and inhibition of histone deacetylase 8 by monovalent cations, Journal of Biological Chemistry, 285, 6036, 10.1074/jbc.M109.033399 Wu, 2010, A proton-shuttle reaction mechanism for histone deacetylase 8 and the catalytic role of metal ions, Journal of the American Chemical Society, 132, 9471, 10.1021/ja103932d Wang, 2007, Zinc binding in HDAC inhibitors: a DFT study, Journal of Organic Chemistry, 72, 5446, 10.1021/jo070739s Tavakol, 2009, Computational study of simple and water-assisted tautomerism of hydroxamic acids, Journal of Molecular Structure: THEOCHEM, 916, 172, 10.1016/j.theochem.2009.09.032 Wu, 2011, Zinc chelation with hydroxamate in histone deacetylases modulated by water access to the linker binding channel, Journal of the American Chemical Society, 133, 6110, 10.1021/ja111104p Kuhn, 2000, Binding of a diverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models, Journal of Medicinal Chemistry, 43, 3786, 10.1021/jm000241h Srinivasan, 1998, Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate DNA helices, Journal of the American Chemical Society, 120, 9401, 10.1021/ja981844+ Bressi, 2010, Exploration of the HDAC2 foot pocket: synthesis and SAR of substituted N-(2-aminophenyl)benzamides, Bioorganic and Medicinal Chemistry Letters, 20, 3142, 10.1016/j.bmcl.2010.03.091 Berman, 2000, The Protein Data Bank, Nucleic Acids Research, 28, 235, 10.1093/nar/28.1.235 Laskowski, 1993, PROCHECK: a program to check the stereochemical quality of protein structures, Journal of Applied Crystallography, 26, 283, 10.1107/S0021889892009944 Hooft, 1996, Errors in protein structures, Nature, 381, 272, 10.1038/381272a0 Colovos, 1993, Verification of protein structures: patterns of nonbonded atomic interactions, Protein Science, 2, 1511, 10.1002/pro.5560020916 Luthy, 1992, Assessment of protein models with three-dimensional profiles, Nature, 356, 83, 10.1038/356083a0 Pontius, 1996, Deviations from standard atomic volumes as a quality measure for protein crystal structures, Journal of Molecular Biology, 264, 121, 10.1006/jmbi.1996.0628 Kaminski, 2001, Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides†, Journal of Physical Chemistry B, 105, 6474, 10.1021/jp003919d Jacobson, 2002, On the role of the crystal environment in determining protein side-chain conformations, Journal of Molecular Biology, 320, 597, 10.1016/S0022-2836(02)00470-9 Jacobson, 2004, A hierarchical approach to all-atom protein loop prediction, Proteins: Structure, Function, and Bioinformatics, 55, 351, 10.1002/prot.10613 Watson, 2012, Structure of HDAC3 bound to co-repressor and inositol tetraphosphate, Nature, 10.1038/nature10728 LigPrep, version 2.5, Schrödinger, LLC; New York, NY, 2011. Shelley, 2007, Epik: a software program for pKa prediction and protonation state generation for drug-like molecules, Journal of Computer-Aided Molecular Design, 21, 681, 10.1007/s10822-007-9133-z Park, 2011, Estimating binding affinities by docking/scoring methods using variable protonation states, Proteins: Structure, Function, and Bioinformatics, 79, 304, 10.1002/prot.22883 Greenwood, 2010, Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution, Journal of Computer-Aided Molecular Design, 24, 591, 10.1007/s10822-010-9349-1 Saha, 2009, N–K spectra of adenine amino tautomers, Journal of Physics: Conference Series, 185, 012040 Jorgensen, 1996, Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids, Journal of the American Chemical Society, 118, 11225, 10.1021/ja9621760 Cho, 2009, Extension of QM/MM docking and its applications to metalloproteins, Journal of Computational Chemistry, 30, 2609, 10.1002/jcc.21270 Deerfield, 2001, Models for protein–zinc ion binding sites II. The catalytic sites, International Journal of Quantum Chemistry, 83, 150, 10.1002/qua.1207 Dudev, 2000, Metal binding in proteins: the effect of the dielectric medium, Journal of Physical Chemistry B, 104, 3692, 10.1021/jp9941559 Rulíšek, 2000, Theoretical studies of metal ion selectivity. 1: DFT calculations of interaction energies of amino acid side chains with selected transition metal ions (Co2+, Ni2+, Cu2+, Zn2+, Cd2+, and Hg2+), Journal of the American Chemical Society, 122, 10428, 10.1021/ja001265g Solt, 2009, Evaluating boundary dependent errors in QM/MM simulations, Journal of Physical Chemistry B, 113, 5728, 10.1021/jp807277r Delchev, 2004, A DFT study of electron structure, geometry, and keto–enol tautomerism of 3-oxopropionyl halogenides, Monatshefte für Chemie: Chemical Monthly, 135, 371, 10.1007/s00706-003-0132-z Turker, 2012, Tautomerism in 11-hydroxyaklavinone: a DFT study, Scientific World Journal, 2012, 7, 10.1100/2012/526289 Du, 2011, Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM–GBSA calculation, Journal of Computational Chemistry, 32, 2800, 10.1002/jcc.21859 Cho, 2005, Importance of accurate charges in molecular docking: quantum mechanical/molecular mechanical (QM/MM) approach, Journal of Computational Chemistry, 26, 915, 10.1002/jcc.20222 Hayes, 2012, MM-GB(PB)SA calculations of protein–ligand binding free energies Sitkoff, 1994, Accurate calculation of hydration free energies using macroscopic solvent models, Journal of Physical Chemistry, 98, 1978, 10.1021/j100058a043 Carra, 2010, Binding sites of the E. coli DNA recombinase protein to the ssDNA: a computational study, Journal of Biomolecular Structure and Dynamics, 27, 407, 10.1080/07391102.2010.10507327 Kongsted, 2009, How accurate are continuum solvation models for drug-like molecules?, Journal of Computer-Aided Molecular Design, 23, 395, 10.1007/s10822-009-9271-6 Kongsted, 2009, An improved method to predict the entropy term with the MM/PBSA approach, Journal of Computer-Aided Molecular Design, 23, 63, 10.1007/s10822-008-9238-z 2011 Loving, 2009, Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation, Journal of Computer-Aided Molecular Design, 23, 541, 10.1007/s10822-009-9268-1 Yuriev, 2011, Challenges and advances in computational docking: 2009 in review, Journal of Molecular Recognition, 24, 149, 10.1002/jmr.1077 Bertrand, 2010, Inside HDAC with HDAC inhibitors, European Journal of Medicinal Chemistry, 45, 2095, 10.1016/j.ejmech.2010.02.030 Schomburg, 2004, BRENDA, the enzyme database: updates and major new developments, Nucleic Acids Research, 32, D431, 10.1093/nar/gkh081 Oehme, 2012, Effect of atomic charge, solvation, entropy, and ligand protonation state on MM-PB(GB)SA binding energies of HIV protease, Journal of Computational Chemistry, 33, 2566, 10.1002/jcc.23095 Hou, 2010, Assessing the performance of the MM/PBSA and MM/GBSA methods. 1: the accuracy of binding free energy calculations based on molecular dynamics simulations, Journal of Chemical Information and Modeling, 51, 69, 10.1021/ci100275a Weis, 2006, Ligand affinities predicted with the MM/PBSA method: dependence on the simulation method and the force field, Journal of Medicinal Chemistry, 49, 6596, 10.1021/jm0608210 Stoica, 2008, Rapid and accurate prediction of binding free energies for Saquinavir-Bound HIV-1 proteases, Journal of the American Chemical Society, 130, 2639, 10.1021/ja0779250